PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7915317-1	1994	Administration of the irreversible cholinesterase inhibitor isoflurophate (diisopropylfluorophosphate, DFP) before 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhanced the loss in tyrosine hydroxylase activity and dopamine and 3,4-dihydroxy-phenylacetic acid content in the striatum of mice in a dose-dependent manner.	Isoflurophate	60-73	butyrylcholinesterase	Mus musculus	35-49	
2993935-1	1985	The irreversible cholinesterase inhibitor diisopropylphosphofluoridate (DFP) causes a naloxone-sensitive antinociceptive effect in laboratory animals.	Isoflurophate	42-70	butyrylcholinesterase	Mus musculus	17-31	
2993935-1	1985	The irreversible cholinesterase inhibitor diisopropylphosphofluoridate (DFP) causes a naloxone-sensitive antinociceptive effect in laboratory animals.	Isoflurophate	72-75	butyrylcholinesterase	Mus musculus	17-31	
32359085-5	2020	Next, we investigated DFP effect on ChE inhibition.	Isoflurophate	22-25	butyrylcholinesterase	Mus musculus	36-39	
7867909-10	1994	PTE (16.8 U/animal, 4 micrograms/10 g body wt, iv) reduced the inhibition of brain and serum ChE activities after PO and diisopropyl fluorophosphate exposure.	Isoflurophate	121-148	butyrylcholinesterase	Mus musculus	93-96	
7915317-1	1994	Administration of the irreversible cholinesterase inhibitor isoflurophate (diisopropylfluorophosphate, DFP) before 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhanced the loss in tyrosine hydroxylase activity and dopamine and 3,4-dihydroxy-phenylacetic acid content in the striatum of mice in a dose-dependent manner.	Isoflurophate	75-101	butyrylcholinesterase	Mus musculus	35-49	
8365583-2	1993	These erythrocytes thereby gain the ability to rapidly hydrolyze alkylphosphate cholinesterase (ChE) inhibitors such as diisopropyl fluorophosphate (DFP).	Isoflurophate	120-147	butyrylcholinesterase	Mus musculus	80-94	
8365583-2	1993	These erythrocytes thereby gain the ability to rapidly hydrolyze alkylphosphate cholinesterase (ChE) inhibitors such as diisopropyl fluorophosphate (DFP).	Isoflurophate	120-147	butyrylcholinesterase	Mus musculus	96-99	
8365583-2	1993	These erythrocytes thereby gain the ability to rapidly hydrolyze alkylphosphate cholinesterase (ChE) inhibitors such as diisopropyl fluorophosphate (DFP).	Isoflurophate	149-152	butyrylcholinesterase	Mus musculus	80-94	
8365583-2	1993	These erythrocytes thereby gain the ability to rapidly hydrolyze alkylphosphate cholinesterase (ChE) inhibitors such as diisopropyl fluorophosphate (DFP).	Isoflurophate	149-152	butyrylcholinesterase	Mus musculus	96-99	
1776688-1	1991	A sensitive enzymatic assay to measure cholinesterase activity in serum using liquid chromatography with electrochemical detection has been devised and used to examine cholinesterase inhibition in mice treated with diisopropyl phosphorofluoridate.	Isoflurophate	215-246	butyrylcholinesterase	Mus musculus	39-53	
1776688-1	1991	A sensitive enzymatic assay to measure cholinesterase activity in serum using liquid chromatography with electrochemical detection has been devised and used to examine cholinesterase inhibition in mice treated with diisopropyl phosphorofluoridate.	Isoflurophate	215-246	butyrylcholinesterase	Mus musculus	168-182	
1776688-7	1991	The mean +/- SE serum cholinesterase activity found for controls and mice treated with diisopropyl phosphofluoridate (6.3 mg/kg, ip, 24 h prior) was 158.7 +/- 5.7 mumol/ml/h and 36.6 +/- 3.1 mumol/ml/h, respectively (P less than 0.001).	Isoflurophate	87-116	butyrylcholinesterase	Mus musculus	22-36